nelfinavir has been researched along with Aging in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bressolle, F; Compagnucci, A; Faye, A; Giaquinto, C; Gibbs, D; Gomeni, R; Jacqz-Aigrain, E; Payen, S | 1 |
| Blanche, S; Firtion, G; Hirt, D; Jullien, V; Pons, G; Rey, E; Treluyer, JM; Urien, S | 1 |
1 trial(s) available for nelfinavir and Aging
| Article | Year |
|---|---|
Bayesian parameter estimates of nelfinavir and its active metabolite, hydroxy-tert-butylamide, in infants perinatally infected with human immunodeficiency virus type 1.
Topics: Aging; Bayes Theorem; Body Weight; Chromatography, High Pressure Liquid; Didanosine; Drug Interactions; Half-Life; HIV Infections; HIV Protease Inhibitors; HIV-1; Humans; Infant; Infant, Newborn; Models, Biological; Nelfinavir; Reverse Transcriptase Inhibitors; Spectrometry, Mass, Electrospray Ionization; Stavudine | 2005 |
1 other study(ies) available for nelfinavir and Aging
| Article | Year |
|---|---|
Age-related effects on nelfinavir and M8 pharmacokinetics: a population study with 182 children.
Topics: Aging; Bayes Theorem; Child; Child, Preschool; Dose-Response Relationship, Drug; Female; HIV Protease Inhibitors; HIV-1; Humans; Infant; Male; Models, Biological; Models, Statistical; Nelfinavir | 2006 |